AB Science S.A. (the "Company” or "AB Science ,” Euronext - FR0010557264 - AB) today announces the successful settlement and delivery of the securities issued as part of its capital increases ...
AB Science has received a binding offer for a Clinical Trial Funding Insurance policy from Medical & Commercial International Ltd. (MCI), Lloyd's Syndicate 1902, for its Phase III clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results